Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program.
Saved in:
| Title: | Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program. |
|---|---|
| Authors: | Epstein MS, Shah ED, Deepak P, Kushnir VM |
| Source: | The American journal of gastroenterology [Am J Gastroenterol] 2019 Jul; Vol. 114 (7), pp. 1017-1019. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 0421030 Publication Model: Print Cited Medium: Internet ISSN: 1572-0241 (Electronic) Linking ISSN: 00029270 NLM ISO Abbreviation: Am J Gastroenterol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
